Home
Conditions
Tardive Dyskinesia

Clinical trial condition

Tardive Dyskinesia

Explore clinical trials studying Tardive Dyskinesia. Study availability and eligibility vary by location and protocol.

34 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Tardive Dyskinesia trial results

Completed

Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

NCT02405091

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Anaheim, California, United States

Glendale, California, United States

Irvine, California, United States

Long Beach, California, United States

View all 48 locations

View Trial Details

Completed

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

NCT01688037

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Little Rock, Arkansas, United States

Anaheim, California, United States

Carson, California, United States

Colton, California, United States

View all 51 locations

View Trial Details

Completed

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder

NCT01393600

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Woodland International Research Group, Inc Little Rock, Arkansas, United States

Synergy Clinical Research National City, California, United States

UCSD Outpatient Psychiatry San Diego, California, United States

PCSD - Feighner Research San Diego, California, United States

View Trial Details

Completed

NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia

NCT01733121

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Costa Mesa, California, United States

Fountain Valley, California, United States

Oceanside, California, United States

Englewood, Colorado, United States

View all 22 locations

View Trial Details

Completed

A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia

NCT02274558

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Little Rock, Arkansas, United States

Anaheim, California, United States

Glendale, California, United States

Irvine, California, United States

View all 54 locations

View Trial Details

Completed

The Assessment of Movement Disorders Utilizing Live Two-Way Video

NCT01467089

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: The Zucker Hillside Hospital Glen Oaks, New York, United States

View Trial Details

Completed

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

NCT01391390

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +9 more
Locations: Beijing HuiLongGuan hospital Beijing, China

View Trial Details

Completed

Levetiracetam Treatment of Tardive Dyskinesia

NCT00291213

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Connecticut Mental Health Center New Haven, Connecticut, United States

View Trial Details

Completed

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

NCT00401089

Conditions: Body Weight, Central Nervous System Diseases, Dyskinesia, Drug-Induced, +21 more
Locations: Queen's University Kingston, Ontario, Canada

Regional Mental Health Care London St. Thomas, Ontario, Canada

Northern Ontario Medical School Thunder Bay, Ontario, Canada

Northwick Park Hospital Harrow, Middlesex, United Kingdom

View Trial Details

Completed

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

NCT01267188

Conditions: Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
Locations: Toronto, Ontario, Canada

View Trial Details

Tardive Dyskinesia

Tardive Dyskinesia trial results

Related conditions